CHD1 and prostate cancer: Loss of CHD1 has previously been linked to an increased risk of postoperative metastasis following radical prostatectomy and has been found to promote spontaneous metastasis formation in animal models of prostate cancer [55], suggesting that these alterations may be associated with more aggressive disease.